Lv41
573 积分 2022-04-24 加入
Sample size of 12 per group rule of thumb for a pilot study
1小时前
已完结
Management changes and survival outcomes for cancer patients after multidisciplinary team discussion; a systematic review and meta-analysis
20天前
已完结
RCA指导下护理干预在深静脉导管非计划性拔管中的应用
21天前
已完结
MPNFS理论下的多方位护理在肿瘤介入治疗中的应用
21天前
已完结
Adaptive Universal Principles for Real-world Observational Studies (AUPROS): an approach to designing real-world observational studies for clinical, epidemiologic, and precision oncology research
24天前
已完结
Efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy as 1st line treatment for patients with non-small cell lung cancer harboring HER2 mutations: Results from LC-SCRUM-Asia
29天前
已完结
Efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy as 1st line treatment for patients with non-small cell lung cancer harboring HER2 mutations: Results from LC-SCRUM-Asia
29天前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
1个月前
已完结
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
1个月前
已完结
RELAY: Final Overall Survival for Erlotinib Plus Ramucirumab or Placebo in Untreated, EGFR-Mutated Metastatic NSCLC
1个月前
已完结
皖公网安备34019202002308
